Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma (Q40446457)

20 September 2017

Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma (English)

1 reference

20 September 2017

1 reference

Lei Wu

1

1 reference

20 September 2017

Wei-Wei Deng

2

1 reference

20 September 2017

Cong-Fa Huang

3

1 reference

20 September 2017

Lin-Lin Bu

4

1 reference

20 September 2017

Guang-Tao Yu

5

1 reference

20 September 2017

Liang Mao

6

1 reference

20 September 2017

Wen-Feng Zhang

7

1 reference

20 September 2017

Bing Liu

8

1 reference

20 September 2017

Zhi-Jun Sun

9

1 reference

20 September 2017

24 February 2017

1 reference

Cancer Immunology, Immunotherapy

20 September 2017

1 reference

20 September 2017

66

1 reference

20 September 2017

627-636

1 reference

20 September 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-017-1968-0

20 September 2017

0 references

cites work

The molecular biology of head and neck cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Utilization of free tissue transfer in head and neck surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Long-term quality of life after total laryngectomy and postoperative radiotherapy versus concurrent chemoradiotherapy for laryngeal preservation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Cancer immunotherapy--revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Cancer immunotherapy achieves breakthrough status: 12th annual meeting of the association for cancer immunotherapy (CIMT), Mainz, Germany, May 6-8, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Immune checkpoint blockade: a common denominator approach to cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Immunomodulating antibodies in the treatment of metastatic melanoma: the experience with anti-CTLA-4, anti-CD137, and anti-PD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Potential of new therapies like anti-PD1 in kidney cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Cutting edge: A monoclonal antibody specific for the programmed death-1 homolog prevents graft-versus-host disease in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

VISTA Regulates the Development of Protective Antitumor Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Disruption of the immune-checkpoint VISTA gene imparts a proinflammatory phenotype with predisposition to the development of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

STAT3 blockade enhances the efficacy of conventional chemotherapeutic agents by eradicating head neck stemloid cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Effector memory T cells, early metastasis, and survival in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Immunology and Immunotherapy of Head and Neck Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

VISTA is an immune checkpoint molecule for human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Targeting STAT3 signaling reduces immunosuppressive myeloid cells in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

The blockade of immune checkpoints in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

CTLA4 blockade reduces immature myeloid cells in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-017-1968-0

10.1007/S00262-017-1968-0

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference